Busey Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Sell
39,239
-2,591
-6% -$151K 0.06% 138
2025
Q4
$2.26M Sell
41,830
-2,515
-6% -$121K 0.06% 136
2025
Q3
$2M Sell
44,345
-1,661
-4% -$77.6K 0.06% 140
2025
Q2
$2.13M Sell
46,006
-168,126
-79% -$8.25M 0.07% 136
2025
Q1
$13.1M Buy
214,132
+63
+0% +$3.67K 0.44% 65
2024
Q4
$12.1M Buy
214,069
+3,487
+2% +$195K 0.4% 66
2024
Q3
$10.9M Sell
210,582
-2,542
-1% -$119K 0.36% 72
2024
Q2
$8.85M Buy
213,124
+2,027
+1% +$90.7K 0.3% 82
2024
Q1
$11.4M Buy
211,097
+3,207
+2% +$163K 0.41% 71
2023
Q4
$10.7M Sell
207,890
-16,850
-7% -$884K 0.41% 73
2023
Q3
$13M Buy
224,740
+584
+0.3% +$35.8K 0.56% 52
2023
Q2
$14.3M Sell
224,156
-702
-0.3% -$47.1K 0.58% 51
2023
Q1
$15.6M Buy
224,858
+8,232
+4% +$581K 0.66% 44
2022
Q4
$15.6M Sell
216,626
-741
-0.3% -$55.9K 0.7% 41
2022
Q3
$15.5M Sell
217,367
-4,452
-2% -$323K 0.76% 33
2022
Q2
$17.1M Buy
221,819
+5,451
+3% +$415K 0.79% 32
2022
Q1
$15.8M Sell
216,368
-7,943
-4% -$533K 0.63% 40
2021
Q4
$14M Sell
224,311
-10,353
-4% -$607K 0.53% 53
2021
Q3
$13.9M Buy
234,664
+28,086
+14% +$1.85M 0.56% 50
2021
Q2
$13.8M Buy
206,578
+1,300
+0.6% +$84.8K 0.65% 42
2021
Q1
$13M Buy
205,278
+13,126
+7% +$817K 0.65% 42
2020
Q4
$11.9M Sell
192,152
-1,688
-0.9% -$104K 0.68% 36
2020
Q3
$11.7M Sell
193,840
-471
-0.2% -$28.3K 0.75% 34
2020
Q2
$11.4M Buy
194,311
+69,216
+55% +$4.14M 0.79% 32
2020
Q1
$6.97M Buy
125,095
+3,557
+3% +$217K 0.57% 47
2019
Q4
$7.8M Buy
121,538
+90,384
+290% +$5.18M 0.51% 53
2019
Q3
$1.58M Buy
31,154
+12,374
+66% +$582K 0.11% 138
2019
Q2
$851K Sell
18,780
-431
-2% -$20.1K 0.08% 128
2019
Q1
$917K Buy
19,211
+298
+2% +$14.8K 0.08% 121
2018
Q4
$983K Sell
18,913
-220
-1% -$11.8K 0.1% 112
2018
Q3
$1.19M Buy
19,133
+653
+4% +$38.8K 0.11% 106
2018
Q2
$1.02M Buy
18,480
+23
+0.1% +$1.24K 0.1% 110
2018
Q1
$1.17M Sell
18,457
-444
-2% -$28.6K 0.12% 103
2017
Q4
$1.16M Buy
18,901
+1,642
+10% +$103K 0.15% 95
2017
Q3
$1.1M Sell
17,259
-180
-1% -$10.5K 0.13% 97
2017
Q2
$972K Sell
17,439
-20
-0.1% -$1.09K 0.13% 92
2017
Q1
$949K Buy
17,459
+154
+0.9% +$8.45K 0.12% 101
2016
Q4
$1.01M Sell
17,305
-1,447
-8% -$79.1K 0.13% 101
2016
Q3
$1.01M Sell
18,752
-429
-2% -$27.6K 0.13% 95
2016
Q2
$1.41M Sell
19,181
-217
-1% -$15.3K 0.18% 91
2016
Q1
$1.24M Sell
19,398
-2,493
-11% -$157K 0.16% 98
2015
Q4
$1.51M Sell
21,891
-529
-2% -$35K 0.2% 96
2015
Q3
$1.33M Sell
22,420
-464
-2% -$29.4K 0.19% 92
2015
Q2
$1.52M Buy
22,884
+150
+0.7% +$9.88K 0.21% 93
2015
Q1
$1.47M Buy
22,734
+504
+2% +$31.6K 0.2% 94
2014
Q4
$1.31M Hold
22,230
0.18% 98
2014
Q3
$1.14M Sell
22,230
-2,307
-9% -$115K 0.17% 93
2014
Q2
$1.19M Sell
24,537
-1,259
-5% -$62K 0.17% 90
2014
Q1
$1.34M Sell
25,796
-3,928
-13% -$209K 0.2% 75
2013
Q4
$1.58M Buy
29,724
+892
+3% +$45.4K 0.24% 67
2013
Q3
$1.33M Sell
28,832
-1,165
-4% -$51.1K 0.22% 66
2013
Q2
$1.34M Buy
+29,997
New +$1.3M 0.22% 64

Other funds holding BMY

Busey Bank's BMY Position: Q1 2026 in Review

Busey Bank reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q1 2026, selling an estimated $151K and leaving 39,239 shares worth $2.38M. The position accounts for 0.06% of the portfolio, ranked #138.

Busey Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.1M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Busey Bank held 39,239 shares of Bristol-Myers Squibb worth $2.38M as of Q1 2026.
  • Busey Bank sold 2,591 Bristol-Myers Squibb shares in Q1 2026, an estimated $151K.
  • Bristol-Myers Squibb made up 0.06% of Busey Bank's portfolio in Q1 2026, its #138 holding.
  • Busey Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Busey Bank's Bristol-Myers Squibb position peaked at $17.1M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.